Reported Jun 24, 2026 · Ongoing
Alyacen 7/7/7, Norethindrone and Ethinyl Estradiol Tablets USP, 0.5mg/0.035mg, 0.75mg/0.035mg, 1 mg/0.0.35mg, 3 Blister…
Glenmark Pharmaceuticals Inc., USA
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Glenmark Pharmaceuticals Inc., USA · 619 River Dr · Elmwood Park, NJ · 07407-1317
Is this the product you have?
- Alyacen 7/7/7, Norethindrone and Ethinyl Estradiol Tablets USP, 0.5mg/0.035mg, 0.75mg/0.035mg, 1 mg/0.0.35mg, 3 Blister Cards each containing 28 tablets, 28 day regimen, Rx only
- Manufactured byGlenmark Pharmaceuticals Ltd., Colvale-Bardez, Goa 403 513, India
- Manufactured forGlenmark Pharmaceuticals Inc., Mahwah, NJ 07430, NDC 68462-556-29
- Lot codes and dates
- Lot #: 20240411
- Exp
6/30/202620250252
- Exp3/31/2027
Where it was sold
- Nationwide
Why it was recalled
Failed Impurities/Degradation Specifications: This recall is being initiated due to out-of-specification results total impurities.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Glenmark Pharmaceuticals Inc., USA recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.